12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Tuesday's intraday session, several healthcare stocks experienced significant movements. PHAXIAM Therapeutics (PHXM) saw a 22.1% increase, while Travere Therapeutics (TVTX) rose by 20.66%. MSP Recovery (LIFW) and Xenetic Biosciences (XBIO) also saw gains of 18.99% and 17.84%, respectively. Cerevel Therapeutics (CERE) and Kala Bio (KALA) shares went up by 16.28% and 15.92%. On the downside, Replimune Group (REPL) dropped by 44.5%, iBio (IBIO) by 43.66%, Seelos Therapeutics (SEEL) by 25.26%, Mainz Biomed (MYNZ) by 25.16%, GRI Bio (GRI) by 23.35%, and Brainstorm Cell (BCLI) by 16.45%.
December 05, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Brainstorm Cell's stock declined by 16.45% with a market value of $16.3 million.
The stock's downturn could indicate a bearish trend that may affect its short-term market performance.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
NEGATIVE IMPACT
GRI Bio's stock fell by 23.35% with a market cap of $1.8 million.
The decline in stock price reflects negative market sentiment that could persist in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 90
NEGATIVE IMPACT
iBio's stock declined by 43.66% with a market value of $2.1 million.
The substantial drop in price could indicate further short-term downside risk for the stock.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Mainz Biomed's stock fell by 25.16% with a market value of $24.2 million.
The drop in stock price may lead to continued short-term negative performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Replimune Group's shares fell by 44.5% with a market cap of $403.5 million.
The sharp decline indicates a strong negative sentiment that could continue to pressure the stock in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Seelos Therapeutics' stock decreased by 25.26% with a market value of $10.7 million.
The significant decline could suggest bearish investor sentiment and potential short-term downward movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Cerevel Therapeutics' stock increased by 16.28% with a market cap of $6.6 billion.
The stock's significant gain is a positive indicator for short-term performance, potentially leading to further increases.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Kala Bio's shares went up by 15.92% with a market value of $20.2 million.
The stock's upward movement could be a sign of short-term bullishness among investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
MSP Recovery's stock went up by 18.99% with a market cap of $57.2 million.
The increase in stock price reflects a positive market reaction that could continue in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
PHAXIAM Therapeutics' stock rose by 22.1% with a market cap of $31.1 million.
The significant intraday gain suggests positive investor sentiment which could lead to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Travere Therapeutics' stock increased by 20.66% with a market cap of $570.3 million.
The substantial rise in stock price could attract more attention and potentially lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Xenetic Biosciences' shares rose by 17.84% with a market cap of $6.4 million.
The positive movement in stock price could suggest short-term upward momentum for the stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90